In Brief
This article was originally published in The Tan Sheet
Executive Summary
FDA encourages disclosures at public hearings
You may also be interested in...
Novel Nicotine Products’ Potential in Harm Reduction Gets Appropriators’ Nod
In its report on the fiscal 2016 spending bill it approved for FDA and USDA, the Appropriation Committee says sustaining 2007 cut-off date is unfair to electronic cigarettes and other yet-regulated tobacco and nicotine products already available.
Novel Nicotine Products’ Potential in Harm Reduction Gets Appropriators’ Nod
In its report on the fiscal 2016 spending bill it approved for FDA and USDA, the Appropriation Committee says sustaining 2007 cut-off date is unfair to electronic cigarettes and other yet-regulated tobacco and nicotine products already available.
E-Cigarettes Spark Evolution Of FDA’s Nicotine-Containing Medical Product Regulation
FDA’s tobacco, drug and medical device centers are discussing “some sort of jurisdictional policy” to “determine how to evolve the regulation of therapeutic nicotine products,” including OTC drugs, says tobacco program head Mitch Zeller.